Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Wu H, Wang G, Gao E, Zhang L, Zhu Y, Zhang J, Liu Z. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carring a homozygous mutation in COL4A3 gene. Stem Cell Res. 2021;56:102557.

Qiu S, Zhang X, Zhang L, Liu Z, Wang L, Jin Z-B, Xiao P. Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome type 2 caused by biallelic variants in the USH2A gene. Stem Cell Res. 2023;69:103101.

Ahmed E, Sansac C, Fieldes M, Bergougnoux A, Bourguignon C, Mianné J, Arnould C, Vachier I, Assou S, Bourdin A, et al. Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD). Stem Cell Res. 2018;33:15-19.

Breyer M, Klein T, Klug K, Klopocki E, Üçeyler N. Generation of the induced pluripotent stem cell line UKWNLi005-A derived from a patient with the GLA mutation c.376A > G of unknown pathogenicity in Fabry disease. Stem Cell Res. 2022;61:102747.

Calamaio S, Serzanti M, Morlino S, Massardi M, Ritelli M, Piovani G, Colombi M, Cortellini V, Castori M, Dell'Era P, et al. Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant. Stem Cell Res. 2022;63:102837.

Sun X, Zhou X, Xiao X, Chi J, Dong B, Wang Y. Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene. Stem Cell Res. 2020;45:101802.

Yu X, Wang H, Xiao F, Jiang S, Li K, Chen Q, Wang G, Kong F, Zhao S. Generation of the integration-free induced pluripotent stem cell line (FHUSTCi001-A) from a patient with glomerulopathy with fibronectin deposits harboring FN1 mutation. Stem Cell Res. 2022;61:102751.

Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res. 2021;54:102432.

Del Rio NM, Huang L, Murphy L, Babu JSuresh, Daffada CMatthew, Haynes WJohn, Keck JG, Brehm MA, Shultz LD, Brown ME. Generation of the NeoThy mouse model for human immune system studies. Lab Anim (NY). 2023;52(7):149-168.

Alari V, Russo S, Rovina D, Gowran A, Garzo M, Crippa M, Mazzanti L, Scalera C, Prosperi E, Giardino D, et al. Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829A > T, p.(Lys1277*). Stem Cell Res. 2018;30:175-179.

Azzam SKassem, Alsafar H, Sajini AA. Generation of the UAE's first Emirati induced pluripotent stem cell line KUSTi001-A from peripheral blood derived CD34+ hematopoietic cells. Stem Cell Res. 2022;63:102853.

Metzler E, Telugu N, Diecke S, Spuler S, Escobar H. Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B, MDCi012-B, MDCi013-B) from the same donor. Stem Cell Res. 2020;48:101987.

Ishikawa K-I, Shiga T, Yoshino H, Nishioka K, Hattori N, Akamatsu W. Generation of three clones (JUCGRMi002-A, B, C) of induced pluripotent stem cells from a Parkinson's disease patient with SNCA duplication. Stem Cell Res. 2023;74:103296.

Paredes BDiaz, Martins GLouise Soa, Azevedo CMachado, Sampaio GLouise De, Nonaka CKymie Vasq, da Silva KNunes, Soares MBotelho Pe, Santos RRibeiro Do, Souza BSolano De. Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies. Stem Cell Res. 2019;38:101454.

Lahm H, Stieglbauer S, Neb I, Doppler S, Schneider S, Dzilic E, Lange R, Krane M, Dreßen M. Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 g. Stem Cell Res. 2023;69:103123.

Valetdinova KR, Maretina MA, Vyatkin YV, Perepelkina MP, Egorova AA, Baranov VS, Kiselev AV, Gershovich PM, Zakian SM. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C. Stem Cell Res. 2020;48:101941.

Souidi M, Amédro P, Meyer P, Desprat R, Lemaître J-M, Rivier F, Lacampagne A, Meli AC. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). Stem Cell Res. 2020;49:102094.

Mondéjar-Parreño G, Jahng JWS, Belbachir N, Wu BC, Zhang X, Perez MV, Badhwar N, Wu JC. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome. Stem Cell Res. 2021;54:102402.

Ishikawa K-I, Ishiguro M, Li Y, Nishioka K, Hattori N, Akamatsu W. Generation of three hiPSC clones from a Parkinson's disease patient with a heterozygous variant of VPS35 p.D620N. Stem Cell Res. 2022;60:102739.

Tofoli FA, Chien HFen, Barbosa EReis, Pereira LV. Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations. Stem Cell Res. 2019;39:101519.

Schuster J, Fatima A, Sobol M, Norradin FHikmet, Laan L, Dahl N. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations. Stem Cell Res. 2019;39:101523.

Canac R, Caillaud A, Cimarosti B, Girardeau A, Hamamy H, Reversade B, Bonnard C, Sayed ZRAl, David L, Poschmann J, et al. Generation of three human induced pluripotent stem cell lines with IRX5 knockout and knockin genetic editions using CRISPR-Cas9 system. Stem Cell Res. 2021;58:102627.

Pandolfi EC, Rojas EJ, Sosa E, Gell JJ, Hunt TJ, Goldsmith S, Fan Y, Silber SJ, Clark AT. Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research. Stem Cell Res. 2019;40:101576.

Pandolfi EC, Hunt TJ, Goldsmith S, Hurlbut K, Silber SJ, Clark AT. Generation of three human induced pluripotent stem cell sublines (UCLAi005-A, UCLAi005-B and UCLAi005-C) for reproductive science research. Stem Cell Res. 2021;54:102409.

Pandolfi EC, Hunt TJ, Goldsmith S, Hurlbut K, Silber SJ, Clark AT. Generation of three human induced pluripotent stem cell sublines (UCLAi004-A, UCLAi004-B, and UCLAi004-C) for reproductive science research. Stem Cell Res. 2021;54:102446.

Pages